The Effects of the COVID-19 Pandemic on Cardiac Surgery Volumes and Outcomes in New Zealand
DOI:
https://doi.org/10.1532/hsf.4719Keywords:
Cardiothoracic Surgery, COVID-19, Coronavirus, New Zealand, PandemicAbstract
Aim:
New Zealand adopted an “elimination strategy” in response to the 2020 COVID pandemic with strict early border controls and early national lockdowns. The international experience of cardiac surgery provision during the COVID pandemic was of reduced case numbers, difficulties with the provision of elective surgery and in some cases increased morbidity associated with waiting for surgery and from developemnt of the infection in post operative patients. We aim to review the effects the COVID-19 pandemic has had on adult cardiac surgery volumes and outcomes in the Wellington region.
Method:
Utilising local data submitted to the New Zealand National cardiac surgical database, we analysed all cardiac operations completed at a tertiary cardiothoracic centre between January 1st 2019 till December 31st 2020. The COVID-19 lockdown period (March-April 2020) was compared with its’ 2019 counterpart as well as the sequential months to analyse for any ‘rebound’ effect. Number of surgeries, proportion of elective cases, and surgery type were assessed.
Results:
The lockdown period of March-April/2020 showed a higher number of cardiac surgery cases per month compared to a the same period in 2019 (48.5 vs 39.0 cases/month, P=0.74). A surge in acute cases was noted in September–December 2020 with 57 acute operations completed, compared to 23 for the corresponding time period in 2019.
Conclusion:
The New Zealand response to the COVID pandemic resulted in low relative rates of community transmission and only a small number of patients admitted to hospital. We did not see a reduction in routine cardiac operations or changes in clincial outcome over this period. Despite the lockdown period, due to low numbers of community and COVID cases in our ICU and hospital we were able to maintain a full operating capacity throughout. We did observe an increase in acute cases following the lockdown likely due to the reduced access to routine cardiology clinics and deferrable diagnostic services.
References
Casey L, Khan N, Healy D. 2020. The impact of the COVID-19 pandemic on cardiac surgery and transplant services in Ireland’s National Centre. Irish Journal of Medical Science. 190(1):13-17.
Haft J, Atluri P, Ailawadi G, Engelman D, Grant M, Hassan A, et al. 2020. Adult Cardiac Surgery During the COVID-19 Pandemic: A Tiered Patient Triage Guidance Statement. The Annals of Thoracic Surgery. 110(2):697-700.
History of the COVID-19 Alert System. 2021. Unite against COVID-19. [cited 30 November 2021]. https://covid19.govt.nz/about-our-covid-19-response/history-of-the-covid-19-alert-system/
Jackson N, Doogue M, Elliott J. 1999. Priority points and cardiac events while waiting for coronary bypass surgery. Heart. 81(4):367-373.
Keizman E, Ram E, Kachel E, Sternik L, Raanani E. 2020. The impact of COVID-19 pandemic on cardiac surgery in Israel. Journal of Cardiothoracic Surgery. 15(1).
Khanna S. 2020. Coronavirus Disease 2019 (COVID‐19) and cardiac surgeon— Are we on the back foot? Journal of Cardiac Surgery. 2020;35(6):1389-1390.
Lawday S. 2021. O4 Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. BJS Open. 5(Supplement_1).
Ministry of Health NZ. 2021. COVID-19 (novel coronavirus). [cited 29 November 2021]. https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus
Nguyen T, Thourani V, Nissen A, Habib R, Dearani J, Ropski A, et al. 2021. The Effect of COVID-19 on Adult Cardiac Surgery in the United States in 717 103 Patients. The Annals of Thoracic Surgery.
Salenger R, Etchill E, Ad N, Matthew T, Alejo D, Whitman G, et al. 2020. The Surge After the Surge: Cardiac Surgery Post–COVID-19. The Annals of Thoracic Surgery. 110(6):2020-2025.
Shehata I, Elhassan A, Jung J, Urits I, Viswanath O, Kaye A. 2020. Elective cardiac surgery during the COVID-19 pandemic: Proceed or postpone? Best Practice & Research Clinical Anaesthesiology. 34(3):643-650.
World Health Organization. 2021. Coronavirus disease (COVID-19). Who.int. 2021 [cited 29 November 2021]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Young P, Psirides A, Streat S, et al. 2021. New Zealand’s staffed ICU bed capacity and COVID-19 surge capacity. New Zealand Medical Journal.
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).